Find Your Funding Opportunity
Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases
Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases
Service
|
Source |
Final Application Due Date |
Funding Available
|
Match Required
|
|---|---|---|---|---|
| Health Care |
Federal
HHS |
See FOA | N/A | No Match Required |
-
Service
-
Source
-
Final Application Due Date
-
Funding Available
-
Match Required
Status
- Expected Number of Awards 15
- Opportunity Type Discretionary
-
CFDA
93.103 -- Food and Drug Administration Research
Description
The purpose of this funding opportunity announcement (FOA) is to fund clinical trials of products evaluating safety and/or efficacy in support of a new indication or change in labeling to address unmet needs in rare diseases or conditions.Additionally, through the funding of collaborative, efficient, and/or innovative clinical trials, FDA expects to increase the number of approved treatments for rare diseases and exert a broad and positive impact on rare disease drug development.
Eligibility
- IHE
- Local Government
- Non-Profit
- Other
- State Government
- Tribal Government
Key Date(s)
- June 23, 2022: Last Updated Date
- June 23, 2022: Forecasted Date